Novel Measurement of Rapid Treatment Success with ReQuestTM: First and Sustained Symptom Relief as Outcome Parameters in Patients with Endoscopy-Negative GERD Receiving 20 mg Pantoprazole or 20 mg Esomeprazole

Publisher： Karger

E-ISSN： 1421-9867|71|3|152-158

ISSN： 0012-2823

Source： Digestion, Vol.71, Iss.3, 2005-06, pp. : 152-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Measurement of Rapid Treatment Success with ReQuestTM: First and Sustained Symptom Relief as Outcome Parameters in Patients with Endoscopy-Negative GERD Receiving 20 mg Pantoprazole or 20 mg Esomeprazole

By  

Digestion, Vol. 75, Iss. 1, 2007-05 ,pp. : 62-68

Karger

Access to resources Recommend Favorite

Determination of ReQuestTM-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies

By  

Digestion, Vol. 75, Iss. 1, 2007-05 ,pp. : 55-61

Karger

Access to resources Recommend Favorite

On-Demand Therapy with Pantoprazole 20 mg as Effective Long-Term Management of Reflux Disease in Patients with Mild GERD: The ORION Trial

By  

Digestion, Vol. 72, Iss. 2-3, 2005-10 ,pp. : 76-85

Karger

Access to resources Recommend Favorite

International Validation of ReQuest™ in Patients with Endoscopy-Negative Gastro-Oesophageal Reflux Disease

By  

Digestion, Vol. 75, Iss. 1, 2007-05 ,pp. : 48-54

Karger

Access to resources Recommend Favorite

Comparison of Pantoprazole 20 mg to Ranitidine 150 mg b.i.d. in the Treatment of Mild Gastroesophageal Reflux Disease

By  

Digestion, Vol. 63, Iss. 3, 2001-05 ,pp. : 163-170

Karger

Access to resources Recommend Favorite